Highest-materiality recent filing
Issued senior secured convertible note to Leviston: $1.2M principal for $1M purchase price, 10% interest, matures Dec 25, 2026.
Mobix Labs signs all-stock deal to acquire Special Project Delivery for up to 4.8M shares
Definitive agreement to acquire SPD, all-stock, consideration up to 4.8M shares of MOBX common stock.
Mobix Labs to acquire Vision Aerial for $15M in stock and cash
Consideration: $12M in Class A common stock (VWAP collar $2-$3/share) plus $3M cash, subject to adjustments.
Mobix Labs issues $2.8M senior secured convertible note to Leviston Resources
Gross proceeds ~$2.3M from $2.8M note; interest 10%, maturity Oct 18, 2026.
Non-binding LOI with Vision Aerial for potential acquisition; active negotiations, no definitive agreement yet.
Mobix Labs: $4M convertible note fully converted into 2.5M shares; new $4M note rights granted
Amended convertible note with Leviston from $3M to $4M, received additional $833,333 cash advance.
Mobix Labs implements 1-for-10 reverse stock split effective April 6, 2026
Every 10 shares of common stock converted to 1 share; no fractional shares issued, cash paid in lieu.
Mobix Labs issues $3M convertible note to Leviston at $2.55M; matures July 31, 2026
Senior secured note with 10% interest; purchase price of $2.55M implies 15% original issue discount.
Mobix Labs shareholders approve all four proposals at annual meeting
Directors elected: Aldrich (62.0M for), Goerner (61.3M for), Samini (20.0M for, Class B).
Mobix Labs reduces stockholder meeting quorum from majority to one-third
Board approved amended and restated bylaws effective February 27, 2026.
Mobix Labs closes $6M public offering of 30M shares at $0.20; net proceeds $5.1M
Offering of 30,000,000 shares of Class A common stock at $0.20 per share closed on January 6, 2026.
Mobix Labs prices $6M oversubscribed public offering of 30M shares
Offering of 30,000,000 shares of common stock for $6.0M gross proceeds; expected closing Jan 7, 2026.
Mobix Labs preliminary FY2025 revenue $9.7-9.9M, up 54% YoY; operating loss cut nearly in half
Net revenue expected $9.7-9.9M vs $6.4M in FY2024, a 54% YoY increase.
Mobix Labs gets Nasdaq extension to Apr 2026; reclasses $6.3M warrants to equity
Nasdaq extended bid-price compliance deadline to April 27, 2026; company previously met $1.00 for 10 days on Sept 11, 2025.
Mobix Labs enters $15.8M at-the-market equity offering with Roth Capital
ATM agreement allows sale of up to $15.8M in Class A common stock at market prices.
Mobix Labs receives $4.5M from warrant exercise; issues new warrants for up to 8.2M shares
Holder exercises 5,486,467 existing warrants at $0.8202/share, gross proceeds ~$4.5M.
$550k Lendspark note convertible at any time into 2.5M shares at $0.70/share; 150k commitment shares issued.
Mobix Labs raises $2.15M through note, loan and equity sale; issues shares and warrants
Issued $550k secured note to Lendspark with 150k commitment shares; convertible at $0.70/share upon default.
Mobix Labs CEO Sansone joins board, personally guarantees $600K loan
Philip Sansone, CEO of Mobix Labs, appointed as Class I director effective Aug 8, 2025, term expiring at 2028 annual meeting.
CEO Fabian Battaglia steps down; remains as senior advisor through 2026
Fabian Battaglia resigned as CEO and board member effective July 25, 2025.
CEO Fabian Battaglia steps down; Philip Sansone appointed CEO of Mobix Labs
Fabian Battaglia steps down as CEO effective July 25, 2025; will remain senior advisor until Dec 31, 2026 and on Board.
Mobix Labs proposes to acquire Peraso (PRSO) at 20% premium in stock-for-stock deal
Mobix will exchange newly issued MOBX shares for each PRSO share at a 20% premium to Peraso's 30-day average closing price through June 10, 2025.
Mobix Labs corrects voting results from May 30 special meeting; all three proposals approved
Corrected voting results for special meeting held May 30, 2025; outcome unchanged, all proposals approved.
Mobix Labs stockholders approve warrant exercise, repricing, and equity grant proposals
Special Meeting held May 30, 2025; 59.2% voting power present (19.1M shares).
Mobix Labs receives Nasdaq delinquency notices for bid price and MVLS requirements
Nasdaq notified Mobix Labs of non-compliance with minimum bid price ($1.00) and MVLS ($35M) requirements.
Mobix Labs appoints Philip Sansone as interim CEO while CEO Battaglia on sick leave
Philip Sansone appointed Interim CEO effective April 10, 2025, replacing CEO Fabian Battaglia who is on sick leave.
Mobix Labs raises $4M in registered direct offering; amends existing warrants
Offers 3,850,000 shares at $0.8202 and 1,026,860 pre-funded warrants at $0.8201.
Mobix Labs shareholders elect directors and ratify auditor at March 3 annual meeting
Kurt Busch and William Carpou elected as Class A directors with ~29.4M and ~29.5M votes for, respectively.
Mobix Labs Q1 2025 revenue $3.17M, exceeds guidance; adj. operating loss improves 28.9%
Revenue of $3.17M for quarter ended Dec 31, 2024, exceeding prior guidance; 11-fold YoY increase.
Mobix Labs enters LOI to acquire SCP Manufacturing, second strategic deal in 60 days
SCP Manufacturing produces mission-critical electrical components for aerospace, defense, and commercial applications; based in Nevada.
Mobix Labs files pro forma FY2024 results combining EMI Solutions acquisition
Pro forma net loss of $20.7M on revenue of $7.2M for year ended Sep 30, 2024.
Mobix Labs holders approve four of five special-meeting proposals; charter amendment fails
Stockholders voted on five proposals at January 3, 2025 special meeting; quorum was 66.2% of voting power.
Q4 revenue $3.0M, up 44% from Q3; GAAP loss from operations $11.2M, adjusted loss $3.6M.
Mobix Labs to acquire Spacecraft Components for $18M-$24M; expected to close Q1 2025
Non-binding LOI to buy Spacecraft, a Nevada-based supplier of high-precision components for aerospace, defense, and transport.
Mobix Labs receives Nasdaq minimum bid price deficiency notice; delisting risk
Received Nasdaq notice on Nov 18, 2024 for failure to maintain $1.00 minimum bid price per share.
Preliminary Q4 FY2024 revenue >$2.9M, up 44% sequential; FY2024 revenue >$6.4M, up 426% vs FY2023.
Mobix Labs submits $3.80/share all-cash bid to acquire EMCORE Corp
Mobix proposed to acquire all outstanding EMCORE shares for $3.80 per share cash, a >200% premium to Sep 27 close.
Mobix Labs Q3 FY2024 revenue $2.1M, up 80% sequentially; GAAP operating loss $9.3M
Revenue of $2.1M for quarter ended June 30, 2024, an 80% sequential increase from Q2 2024.
Mobix Labs Enters $4M Private Placement with Pre-Funded and Common Warrants
Mobix Labs (MOBX) raised approximately $4 million in a private placement with an institutional investor, offering 2,877,698 pre-funded warrants and Series A/B warrants at $1.39 per share.
Mobix Labs projects >70% sequential revenue growth to >$2M in current quarter
Sequential revenue growth >70% to exceed $2M for the quarter ending June 2024.
Mobix Labs closes acquisition of RaGE Systems for ~$12M in stock and cash
Consideration includes 3,214,045 Class A shares and $2M cash payable over three tranches; up to $8M earn-out.
Mobix Labs acquires RaGE Systems for $12M in stock and cash; merger expected May 2024
Total consideration of $12M: $10M in Mobix Class A common stock (based on VWAP) + $2M cash, with $200K at closing, $1M Nov 2024, $800K Apr 2025.
Mobix Labs Q2 revenue $1.1M (+302% seq); acquires RaGE Systems; guides Q3 $1.8-2.2M
Q2 fiscal 2024 revenue $1.1M, up 302% sequentially from $0.29M.
Mobix Labs to acquire RaGE Systems for up to $20M in cash, stock, and earn-outs
Total consideration: ~$2M cash + ~$10M stock + up to $8M earn-out over eight fiscal quarters.
Mobix Labs enters $100M committed equity facility with B. Riley
Up to $100M of Class A common stock can be sold to B. Riley at company's discretion over 36 months.
Mobix Labs projects >250% sequential revenue growth, topping $1M this quarter
Projects greater than 250% revenue growth over prior quarter.
Warrant strike cut 50% to $5.79; director change and $3M placement by new director Long
Warrant exercise price adjusted from $11.50 to $5.79; redemption trigger lowered from $18.00 to $9.06.
Chavant completes merger with Mobix Labs, begins trading as MOBX; PIPE and EMI acquisition closed
On Dec 21, 2023, Chavant merged with Mobix Labs; combined company renamed Mobix Labs, Inc. and began trading Dec 22 on Nasdaq (MOBX, MOBXW).
Mobix Labs completes de-SPAC merger with Chavant; trading starts Dec 22 under MOBX
Business combination closed Dec 21, 2023; Chavant renamed Mobix Labs, Inc.
Sage Hill Investors commits $15M PIPE at $10.00/share for 1,500,000 shares of Class A Common Stock.
On April 10, 2025, the Board of Directors (the “Board”) of Mobix Labs, Inc. (the “Company”) appointed Philip Sansone as Interim Chief Executive Officer of the Company, effective immediately.
Dr. Ma resigned from the Company’s Board of Directors (the “Board”) as a director, effective January 22, 2024.
On January 22, 2024, the Board appointed Mr. Michael Long as a Class III director of the Board effective immediately for a term expiring at the 2026 Annual Meeting of Stockholders.
on July 19, 2021, Patrick Ennis, Karen Kerr and Bernhard Stapp (collectively, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
on July 19, 2021, Patrick Ennis, Karen Kerr and Bernhard Stapp (collectively, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
on July 19, 2021, Patrick Ennis, Karen Kerr and Bernhard Stapp (collectively, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
Max materiality 0.90 · Median 0.65 · Most common event other_material